Literature DB >> 6721987

Pethidine binding in plasma: effects of methodological variables.

C La Rosa, L E Mather, D J Morgan.   

Abstract

Several methodological variables potentially influencing the plasma protein binding of [14C]-pethidine in vitro were investigated using equilibrium dialysis and rigorous pH control. Ionic strength of buffer, pethidine concentration and 21 days of plasma samples frozen to -8 degrees C did not affect the outcome of the binding experiments. Unbound fraction decreased with increasing temperatures between 25 degrees C and 37 degrees C. Unbound fraction decreased with increased pH between pH 7.0 and 8.0; the mean unbound fraction at an equilibrium pH of 7.4 and at 37 degrees C was 0.58 (s.d. 0.03, n = 58). It is likely that previous reports of pethidine unbound fraction as being between 0.2 and 0.4 represent artefacts caused by inadequate pH control during dialysis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6721987      PMCID: PMC1463402          DOI: 10.1111/j.1365-2125.1984.tb02365.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  15 in total

1.  Effects of pH on protein binding of lidocaine.

Authors:  R G Burney; C A DiFazio; J A Foster
Journal:  Anesth Analg       Date:  1978 Jul-Aug       Impact factor: 5.108

2.  Binding of digoxin to human serum proteins: influence of pH on the binding of digoxin to human albumin.

Authors:  A Brock
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1974-04

3.  Plasma protein binding of fentanyl.

Authors:  S Bower
Journal:  J Pharm Pharmacol       Date:  1981-08       Impact factor: 3.765

4.  Meperidine kinetics in man. Intravenous injection in surgical patients and volunteers.

Authors:  L E Mather; G T Tucker; A E Pflug; M J Lindop; C Wilkerson
Journal:  Clin Pharmacol Ther       Date:  1975-01       Impact factor: 6.875

5.  Binding of tricyclic antidepressants and perazine to human plasma. Methodology and findings in normals.

Authors:  M Brinkschulte; U Breyer-Pfaff
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-07       Impact factor: 3.000

6.  A radioreceptor assay for propranolol and 4-hydroxypropranolol.

Authors:  C L Rochester; D E Gammon; E Shane; J P Bilezikian
Journal:  Clin Pharmacol Ther       Date:  1980-07       Impact factor: 6.875

7.  Determination of meperidine blood to plasma concentration ratio (lambda) - effect of temperature and pH.

Authors:  A J Jackson
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1981-05

8.  The effect of chloride on the binding of warfarin to albumin as a function of pH.

Authors:  J Wilting; W F van der Giesen; L H Janssen
Journal:  Biochem Pharmacol       Date:  1981-05-15       Impact factor: 5.858

9.  Meperidine binding in maternal and fetal plasma.

Authors:  R L Nation
Journal:  Clin Pharmacol Ther       Date:  1981-04       Impact factor: 6.875

10.  Pethidine binding to blood cells and plasma proteins in old and young subjects.

Authors:  L Holmberg; I Odar-Cederlöf; J L Nilsson; M Ehrnebo; L O Boréus
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

View more
  2 in total

1.  pH lability in serum during equilibrium dialysis.

Authors:  O Brørs; S Jacobsen
Journal:  Br J Clin Pharmacol       Date:  1985-07       Impact factor: 4.335

2.  Pethidine binding in whole blood: methodology and clinical significance.

Authors:  C La Rosa; D J Morgan; L E Mather
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.